nad has been researched along with bumetanide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haas, M; Harris, HW; Hwang, SJ; Kashgarian, M; Otuechere, G; Silva, P; Sullivan, MR; Yalla, S; Zeidel, ML | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
2 other study(ies) available for nad and bumetanide
| Article | Year |
|---|---|
Transport defects of rabbit medullary thick ascending limb cells in obstructive nephropathy.
Topics: Animals; Biological Transport, Active; Bumetanide; Carrier Proteins; Cell Membrane; Furosemide; Kidney Diseases; Kidney Medulla; Kinetics; NAD; Ouabain; Oxygen Consumption; Rabbits; Reference Values; Sodium; Sodium-Potassium-Chloride Symporters; Sodium-Potassium-Exchanging ATPase; Ureteral Obstruction | 1993 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |